As a result, Incyte will receive a milestone payment of $35m from Lilly related to the NDA submission. If baricitinib is granted U.S. regulatory approval, Incyte will receive
Under the deal, CELLforCURE will implement cGMP manufacturing processes designed and developed by Cellectis. The company will manufacture cGMP clinical batches for UCART123, the lead engineered T-cell product
According to the company’s latest report, this slight increase in sales, which will occur across the seven major markets (7MM) of the US, France, Germany, Italy, Spain, the
The Catapult was announced by the Chancellor of the Exchequer, George Osborne in July 2015. It will be located in the north-west of England at Alderley Park, recognising
Under the FDA’s rare pediatric disease priority review voucher program, the sponsor may be eligible for a voucher that can be used to obtain a priority review for
The consortium is developing a novel treatment for clotting disorders, targeting antithrombin III, a protein which inhibits blood clotting. Members will provide their know-how and expertise to produce
The contracts are for global clinical trials of novel drugs for Alzheimer’s disease which span the three major phases of drug development and are expected to run for
Shire agreed to purchase US-based Baxalta for $32bn after six months of hot pursuit. Shire reported that it has offered to pay $18 in cash and 0.1482 of
The trial is being performed at The University of Texas MD Anderson Cancer Center with Vivek Subbiah, M.D., as the Principal Investigator. Dr. Subbiah is an Assistant Professor
Nivalis president and CEO Jon Congleton said: "The Orphan Drug Designation represents an important milestone in the development and regulatory strategy for N91115 and underscores the unmet need
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.